Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
about
Down syndrome and leukemia: insights into leukemogenesis and translational targetsChildhood acute lymphoblastic leukemia: Integrating genomics into therapyChildhood Acute Lymphoblastic Leukemia: Progress Through CollaborationNon-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.Prognostic factors and treatment of pediatric acute lymphoblastic leukemia.First do no harm: infectious deaths in pediatric ALL.Biology of childhood acute lymphoblastic leukemia.Exploration of the treatment challenges in men with intellectual difficulties and testicular cancer as seen in Down syndrome: single centre experience.Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations.Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.Haematopoietic development and leukaemia in Down syndrome.Child and adolescent Down syndrome-associated leukaemia: the Irish experience.Stem and progenitor cell dysfunction in human trisomies.Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Down syndrome and the complexity of genome dosage imbalance.Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.Recent advances in the management of pediatric acute lymphoblastic leukemia.Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia.Blinatumomab activity in a patient with Down syndrome B-precursor acute lymphoblastic leukemia.A strategy for the clinical remission of acute lymphoblastic leukemia elicited by treatment of β-thalassemia major: A case report.Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.Acute promyelocytic leukaemia with a PML-RARA insertional translocation and a chromosome 21 abnormality in XYY syndrome: case report.Philadelphia chromosome-positive acute lymphoblastic leukemia and Down syndrome.Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.Genetics and epigenetics of pediatric leukemia in the era of precision medicineImpact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia
P2860
Q26770335-734E24F1-8FB4-4EE9-AFE4-5068E6EA4C8BQ28080463-AD88E636-B149-4F83-BAD4-8D5F565D3224Q28087637-54E6808C-CFE1-4D94-8B01-F780DF905408Q33557148-9795236E-7A51-4F54-93D4-9E876B0CD5DCQ33615910-82B23D47-38CD-4FA5-8EF3-CDE1D080F7D5Q33698398-6A2B0D5D-4A58-47D4-B857-89C4290AB386Q33770150-628E3560-1D3D-4563-B65B-3017941CD4F3Q34047922-F8CEE7C7-0D0F-4864-9EEA-83BB93196AD3Q34605953-6AE2F6FF-AB9F-4315-9250-A1241EC73050Q35678021-5E7E62A1-134B-4191-A735-16565DB7C6DBQ36334267-332ABB1E-8CD2-478E-A9FF-B8440FE60E00Q36420748-3EE102F9-7545-433A-93E0-4CBB1847270FQ38243161-9ED4A789-0436-4A58-9698-9BF67078579CQ38262596-37D013A5-3DB4-4C9F-94EB-071BC7ACF2B9Q38292512-BA0ADDB5-0176-4D68-9432-9B47D53364F1Q38892345-08A55DEA-C87A-47C6-AB06-8253F49A44B3Q39041475-52C37452-1DD1-4040-9C24-BA4F9B2345C2Q39060506-1C16BD6F-9155-489D-881A-B3F08CD900A7Q40681392-9CE2039A-691F-4B24-AFAE-BC0B3A0FDC25Q41000106-CFCAF937-1EFA-4129-A7AC-ED76C478F6EBQ41724174-5B6EB498-C477-4ACA-827E-A524B69ED2B3Q45105040-5AC9617D-741B-4D80-8273-8D5B0E092273Q45233800-18358F9A-9234-4A56-BEAF-8F9656275710Q46158135-12C4089D-B56A-4678-A7D5-A8FB5D0887A0Q47566809-33445147-054B-4805-B3E5-731DD7BA5FA1Q47786126-126D0B51-D5AD-4800-A87B-AA3C846BB2BCQ49414066-572F53C8-9EEF-42B6-8088-661619015052Q50079472-49CA906F-7B48-4946-B5EA-2536D9FC96E6Q50220583-95E4D43A-D8F6-4E9B-A3D7-1E35384F0DE7Q51053584-F5E3D523-6C4F-49C4-9379-FFA74CB7C1C0Q52863144-4AD56494-DFA5-4542-93A0-9A41403686C6Q54336349-13054F5D-C575-4A04-95BE-E46B3B336C3EQ57175475-34F671BF-03BD-4596-9359-674A0BDB0CFAQ58317408-60CD0B28-7129-4870-BF40-32109E863E58
P2860
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@en
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@nl
type
label
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@en
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@nl
prefLabel
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@en
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@nl
P2093
P2860
P50
P1433
P1476
Acute lymphoblastic leukemia i ...... he Ponte di Legno study group.
@en
P2093
Andrea Biondi
Atsushi Manabe
Batia Stark
C Michel Zwaan
Carin M Korbijn
Der-Cheng Liang
Erik Forestier
Georg Mann
Gunnar Cario
P2860
P356
10.1182/BLOOD-2013-06-509463
P407
P50
P577
2013-11-12T00:00:00Z